Susan Symes, CCRP

Massachusetts General HospitalBoston, Massachusetts - 02114 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS1
- SINCE2008

An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma
December 2008 - March 2012
Mesothelioma
Morab-009 Amatuximab By Iv On Days 1 And 8 Every 21 Days For 6 Cycles.



